65 related articles for article (PubMed ID: 11416953)
1. Neotrofin clinical trials show promise.
Am J Alzheimers Dis Other Demen; 2001; 16(1):8-9. PubMed ID: 11416953
[No Abstract] [Full Text] [Related]
2. The effects of Neotrofin on septodentate sprouting after unilateral entorhinal cortex lesions in rats.
Ramirez JJ; Parakh T; George MN; Freeman L; Thomas AA; White CC; Becton A
Restor Neurol Neurosci; 2002; 20(1-2):51-9. PubMed ID: 12237496
[TBL] [Abstract][Full Text] [Related]
3. Brain metabolic effects of Neotrofin in patients with Alzheimer's disease.
Potkin SG; Alva G; Keator D; Carreon D; Fleming K; Fallon JH
Brain Res; 2002 Sep; 951(1):87-95. PubMed ID: 12231461
[TBL] [Abstract][Full Text] [Related]
4. Use of a false recognition paradigm in an Alzheimer's disease clinical trial: a pilot study.
Budson AE; Michalska KJ; Rentz DM; Joubert CC; Daffner KR; Schacter DL; Sperling RA
Am J Alzheimers Dis Other Demen; 2002; 17(2):93-100. PubMed ID: 11954675
[TBL] [Abstract][Full Text] [Related]
5. A pilot study of serotonergic system responsivity in Alzheimer's disease.
Lawlor BA; Mellow AM; Sunderland T; Hill JL; Murphy DL
Psychopharmacol Bull; 1988; 24(1):127-9. PubMed ID: 3290935
[No Abstract] [Full Text] [Related]
6. [Challenging pharmacotherapy in dementia].
Ihl R
MMW Fortschr Med; 2009 Mar; 151(13):46-8. PubMed ID: 19504818
[No Abstract] [Full Text] [Related]
7. Stimulating drugs in Alzheimer's disease.
Stewart A
Mol Med Today; 1997 Oct; 3(10):414-5. PubMed ID: 9358466
[No Abstract] [Full Text] [Related]
8. Switching from donepezil or rivastigmine to galantamine in clinical practice.
Edwards K; Therriault O'connor J; Gorman C
J Am Geriatr Soc; 2004 Nov; 52(11):1965. PubMed ID: 15507085
[No Abstract] [Full Text] [Related]
9. Safety and efficacy of idebenone versus tacrine in patients with Alzheimer's disease: results of a randomized, double-blind, parallel-group multicenter study.
Gutzmann H; Kühl KP; Hadler D; Rapp MA
Pharmacopsychiatry; 2002 Jan; 35(1):12-8. PubMed ID: 11819153
[TBL] [Abstract][Full Text] [Related]
10. Donepezil treatment of patients with severe Alzheimer's disease in a Japanese population: results from a 24-week, double-blind, placebo-controlled, randomized trial.
Homma A; Imai Y; Tago H; Asada T; Shigeta M; Iwamoto T; Takita M; Arimoto I; Koma H; Ohbayashi T
Dement Geriatr Cogn Disord; 2008; 25(5):399-407. PubMed ID: 18391486
[TBL] [Abstract][Full Text] [Related]
11. Clinical effects of high oral dose of donepezil for patients with Alzheimer's disease in Japan.
Nozawa M; Ichimiya Y; Nozawa E; Utumi Y; Sugiyama H; Murayama N; Iseki E; Arai H
Psychogeriatrics; 2009 Jun; 9(2):50-5. PubMed ID: 19604325
[TBL] [Abstract][Full Text] [Related]
12. [Progress is nescessary! New antidementia drugs].
Nemec K; Schubert-Zsilavecz M
Pharm Unserer Zeit; 2002; 31(4):376-80. PubMed ID: 12162067
[No Abstract] [Full Text] [Related]
13. [Outpatient treatment of patients suffering from Alzheimer dementia. Two exploratory studies on the characteristics of therapy in medical practice].
Haupt M; Rosenfeld S; Stoppe G
MMW Fortschr Med; 2004 Aug; 146 Suppl 2():51-6. PubMed ID: 16739359
[TBL] [Abstract][Full Text] [Related]
14. Citicoline. Ferrer Internacional.
Alexandrov AV
Curr Opin Investig Drugs; 2001 Dec; 2(12):1757-62. PubMed ID: 11892942
[TBL] [Abstract][Full Text] [Related]
15. Semi-parametric and non-parametric methods for clinical trials with incomplete data.
O'Brien PC; Zhang D; Bailey KR
Stat Med; 2005 Feb; 24(3):341-58. PubMed ID: 15547952
[TBL] [Abstract][Full Text] [Related]
16. [Starting Alzheimer therapy in early stages whenever possible. Activities of daily living remain intact longer].
Fuchsberger T; Padberg F; Faltraco F; Möller HJ; Hampel H
MMW Fortschr Med; 2002 May; 144(20):36-9. PubMed ID: 12119881
[TBL] [Abstract][Full Text] [Related]
17. Assessing health economic outcome in Alzheimer's disease clinical trials.
Jonsson L
J Nutr Health Aging; 2007; 11(4):353-5. PubMed ID: 17653498
[TBL] [Abstract][Full Text] [Related]
18. A Phase II study targeting amyloid-beta with 3APS in mild-to-moderate Alzheimer disease.
Aisen PS; Saumier D; Briand R; Laurin J; Gervais F; Tremblay P; Garceau D
Neurology; 2006 Nov; 67(10):1757-63. PubMed ID: 17082468
[TBL] [Abstract][Full Text] [Related]
19. Immune-based therapy shows promise.
AIDS Patient Care STDS; 2005 Jun; 19(6):415. PubMed ID: 16041868
[No Abstract] [Full Text] [Related]
20. [Alzheimer's disease: therapeutic perspectives].
Dubois B; De Souza L; Allali G; Kalafat M; Sarazin M
Bull Acad Natl Med; 2008 Feb; 192(2):333-42; discussion 343-4. PubMed ID: 18819687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
